Digital-care firm Firefly Well being is partnering with digital gastrointestinal-health startup Oshi Well being to supply digital digestive care.
As a part of the deal, Firefly members obtain entry to digital visits with a care staff, together with suppliers, dietitians and psychologists. They will additionally use symptom-tracking instruments and message well being coaches to assist life-style modifications.
“Digestive points are among the many most typical complaints we see in our inhabitants, but the options typically miss the mark,” Jeff Greenberg, Firefly cofounder and chief community officer, stated in an announcement.
“Oshi Well being is a pure associate due to its whole-person strategy. With Oshi, we’re excited to maneuver digestive healthcare from ongoing procedures and exams to longitudinal behavioral assist. Collectively, we will rework the affected person expertise for the various people who find themselves determined for efficient digestive-health remedy.”
WHY IT MATTERS
A research printed final 12 months in Gastroenterology discovered greater than 40% of individuals worldwide have practical gastrointestinal problems, like irritable-bowel syndrome or practical dyspepsia.
Firefly and Oshi stated the addition of Oshi to its specialty-care community would save sufferers money and time when addressing digestive-health issues.
“We’re excited to associate with Firefly Well being to make digestive well being handy, accessible and empowering for his or her members,” Oshi Well being CEO Sam Holliday stated in an announcement.
THE LARGER TREND
The virtual-care firm additionally entered into specialty-care agreements final 12 months with the Dana-Farber Most cancers Institute and the Joslin Diabetes Middle.
In October, Firefly launched a virtual-first well being plan geared toward small and midsize employers. The providing consists of digital major and behavioral healthcare, in addition to entry to in-person care by way of its companions. The well being plan launch got here months after the corporate introduced a $40 million Sequence B spherical.
Oshi lately scored $23 million in Sequence A financing, which can go towards scaling its platform.
Different gamers within the digital gastrointestinal-care area embrace Vivante Well being, which final week introduced a $16 million increase; metaMe Well being, which acquired FDA clearance in December for its prescription digital therapeutic geared toward treating belly ache related to IBS in adults; and Daring Well being, which final 12 months launched an app for treating IBS signs.
